University of Manchester scientists working on an app for psychosis therapy receive government funding.

US-based Crown Bioscience acquires Nottingham oncology spin-out.

Epizyme reports second quarter results including milestones reached and completion of its well-bought IPO.

Michigan cancer-fighting biotech spin-out lands $82m in IPO.

Conatus Pharmaceuticals raised $66m in its IPO, before underwriting discounts, but its stock continues to trade below its offer price.

Oncanova Therapeutics closes its initial public offering (IPO) having raised $79.6m net proceeds.

Palomar Health and Qualcomm launch glassware incubator to explore medical application of wearable computing devices such as Google Glass.

Celgene Corporation pays investee company Acetylon Pharmaceuticals $100m upfront and signs development agreement with $500m+ acquisition option.